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Abstract
Background: β-catenin is a key mediator of the canonical Wnt pathway as it associates with
members of the T-cell factor (TCF) family at Wnt-responsive promoters to drive the transcription
of Wnt target genes. Recently, we showed that Rac1 GTPase synergizes with β-catenin to increase
the activity of a TCF-responsive reporter. This synergy was dependent on the nuclear presence of
Rac1, since inhibition of its nuclear localization effectively abolished the stimulatory effect of Rac1
on TCF-responsive reporter activity. We hypothesised that Rac1 plays a direct role in enhancing
the transcription of endogenous Wnt target genes by modulating the β-catenin/TCF transcription
factor complex.
Results:  We employed chromatin immunoprecipitation studies to demonstrate that Rac1
associates with the β-catenin/TCF complex at Wnt-responsive promoters of target genes. This
association served to facilitate transcription, since overexpression of active Rac1 augmented Wnt
target gene activation, whereas depletion of endogenous Rac1 by RNA interference abrogated this
effect. In addition, the Rac1-specific exchange factor, Tiam1, potentiated the stimulatory effects of
Rac1 on the canonical Wnt pathway. Tiam1 promoted the formation of a complex containing Rac1
and β-catenin. Furthermore, endogenous Tiam1 associated with endogenous β-catenin, and this
interaction was enhanced in response to Wnt3a stimulation. Intriguingly, Tiam1 was recruited to
Wnt-responsive promoters upon Wnt3a stimulation, whereas Rac1 was tethered to TCF binding
elements in a Wnt-independent manner.
Conclusion: Taken together, our results suggest that Rac1 and the Rac1-specific activator Tiam1
are components of transcriptionally active β-catenin/TCF complexes at Wnt-responsive
promoters, and the presence of Rac1 and Tiam1 within these complexes serves to enhance target
gene transcription. Our results demonstrate a novel functional mechanism underlying the cross-
talk between Rac1 and the canonical Wnt signalling pathway.
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Introduction
Rac1 GTPase is a member of the Rho family of small
GTPases, which play critical roles in the regulation of var-
ious cellular processes that include reorganization of the
actin cytoskeleton, cell-cycle progression, intercellular
adhesion, and gene expression [reviewed in [1]]. Rho fam-
ily proteins act as molecular switches that cycle between
an inactive GDP-bound state and an active GTP-bound
state. This cycling is regulated by proteins such as guanine
nucleotide exchange factors (GEFs) that activate Rho
GTPases by accelerating GDP to GTP exchange, and
GTPase activating proteins (GAPs) that deactivate Rho
GTPases by increasing their intrinsic rate of GTP hydroly-
sis. Active, GTP-bound Rho GTPases interact with and
activate downstream effector proteins through which they
elicit a vast range of cellular effects.
Mounting evidence strongly implicates the dysregulation
of Rac1 in cancer development. Elevated expression of
Rac1 has been reported in breast, colon, and lung tumours
[2]. Rac1 activity is also upregulated in several colon can-
cer and breast cancer cell lines [3] and is likely attributed
to the aberrant expression of upstream Rac1 regulators.
Overexpression of the Rac1-specific GEF, T-cell lym-
phoma invasion and metastasis 1 (Tiam1), has been
reported in highly invasive breast tumours [4] and colon
carcinomas [5-8], and may contribute to elevated Rac1
signalling in these cancers. One mechanism by which dys-
regulated Rac1 signalling may promote tumourigenesis is
by modulating the activities of various transcription fac-
tors, including nuclear factor-kappa B (NF-κB), activator
protein-1 (AP-1), and signal transducer and activator of
transcription 3 (STAT3), which regulate the transcription
of genes involved in tumourigenic events such as cell pro-
liferation, tumour angiogenesis, and cell survival
[reviewed in [9]].
Most studies regarding Rho GTPases focus on the cyto-
plasmic or membrane-associated functions of these pro-
teins. The recent discovery that some Rho GTPases, for
example Rac1, possess a nuclear localization signal (NLS)
[10] raises the possibility that these GTPases may play
important roles in the nucleus as well. In line with this
possibility, several binding partners for Rho GTPases were
found to have nuclear functions: the Rho effector ROCK2
was reported to increase the histone acetyl transferase
(HAT) activity of p300 [11]; the Rac1 and Cdc42 effector
Pak1 reportedly phosphorylates histone H3 [12]; and the
hematopoietic-specific GEF Vav1 was shown to be a com-
ponent of transcriptionally active promoter-associated
complexes [13]. Despite the emerging significance of Rho
GTPases and their interacting partners in the nucleus,
their nuclear functions remain poorly understood.
The canonical Wnt signalling pathway coordinates vari-
ous cellular processes such as cell proliferation and cell
fate determination during embryonic development and
adult tissue maintenance. Wnt signalling leads to the sta-
bilization and nuclear accumulation of β-catenin, the key
mediator of the pathway. In the nucleus, β-catenin associ-
ates with members of the T-cell factor/lymphoid-
enhancer factor (TCF/LEF) family of HMG-box transcrip-
tion factors to activate the transcription of several target
genes, for example c-Myc [14] and Cyclin D1 [15,16]. Dys-
regulation of the Wnt pathway may arise due to mutations
in key Wnt pathway components, resulting in the inap-
propriate formation of a β-catenin/TCF transcription fac-
tor complex that constitutively activates Wnt target genes.
A considerable amount of evidence has implicated the
aberrant formation of this complex as a pivotal event in
the development of many cancers, including colorectal
cancers[17].
The transcription of Wnt target genes involves a complex
network of interactions that converge at TCF-binding ele-
ments (TBEs) within Wnt-responsive promoters. In the
absence of Wnt signalling, TBE-bound TCFs associate with
transcriptional co-repressors, including Groucho/trans-
ducin-like enhancer of split (TLE) proteins [18-20] and C-
terminal binding protein (CtBP) [21], which maintain
chromatin in a transcriptionally inactive state. Upon acti-
vation of the Wnt pathway, β-catenin binds to TCF, dis-
placing Groucho/TLE and CtBP co-repressors [21,22], and
forming a bipartite transcription factor in which TCF pro-
vides the DNA-binding domain and β-catenin provides
the transactivation domain. The transactivating function
of β-catenin is potentiated by the recruitment of various
cofactors, such as Pygopus [23-25], TATA-binding protein
(TBP)[26], and cyclic AMP response element-binding pro-
tein (CBP)/p300 [27]. Furthermore, functional interac-
tions between components of the Wnt-dependent
transcription factor complex and mediators of other sig-
nalling pathways have been reported. For example,
nuclear components of transforming growth factor-beta
(TGF-β)/Smad [28], estrogen receptor [29], and c-jun N-
terminal kinase (JNK)/c-jun pathways [30] have been
shown to modulate the β-catenin/TCF complex, thereby
influencing the temporal and/or tissue-specific pattern of
Wnt target gene expression.
Several lines of evidence implicate a role for Rho GTPases,
and Rac1 in particular, in the regulation of the Wnt signal-
ling pathway. Both Rac1 and RhoA are activated down-
stream of the non-canonical Wnt pathway, known as the
planar cell polarity (PCP) pathway, and are required for
various movements during vertebrate gastrulation [31].
Other studies have reported the interaction between the
Rho family GEF Asef and adenomatous polyposis coli
(APC), an important component of the Wnt pathway,Molecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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which leads to increased migration of colorectal cancer
cells [32,33]. Recently, we identified Rac1 GTPase as an
important regulator of the canonical Wnt signalling path-
way in colorectal cancer cells [34]. We showed that Rac1
promotes the accumulation of β-catenin in the nucleus,
and synergizes with β-catenin to augment the transcrip-
tion of Wnt-responsive genes in both Wnt-active colorec-
tal cancer cells and Wnt-inactive HEK293 cells. Mutation
of the NLS of Rac1 inhibited its nuclear translocation, and
abolished the stimulatory effects of Rac1 on β-catenin/
TCF-dependent transcription, indicating that the nuclear
presence of Rac1 is critical in mediating canonical Wnt
pathway activation.
In this report, we aimed to elucidate the role of Rac1 in the
transduction of canonical Wnt signals in colorectal cancer
cells. The Rac1-specfic GEF Tiam1 is overexpressed in
many colorectal cancers [5,6], and is a transcriptional tar-
get of the canonical Wnt signalling pathway [6,35]. We
therefore investigated the possible involvement of Tiam1
in Rac1-mediated regulation of the canonical Wnt path-
way. Herein, we demonstrate that Rac1 and its activator
Tiam1 directly modulate Wnt target gene transcription by
associating with the β-catenin/TCF transcription factor
complex at Wnt-responsive promoters. Our results dem-
onstrate a novel functional mechanism underlying the
interplay between Rac1 and the canonical Wnt signalling
pathway, and shed some light on the nuclear roles of Rac1
and Tiam1.
Results
Rac1 associates with β-catenin in the nucleus
We have previously shown that active GTP-bound Rac1,
but not the inactive GDP-bound form, synergizes with β-
catenin to induce the activity of a TCF-responsive reporter
(TOPFlash) [34]. We demonstrated that mutation of the
NLS of Rac1 abolished its ability to translocate into the
nucleus, as well as its ability to synergize with β-catenin in
the activation of the TOPFlash reporter. Furthermore, we
previously reported that active Rac1 interacts with β-cat-
enin via co-immunoprecipitation of whole cell lysates.
Given the functional interaction between Rac1 and β-cat-
enin, and the dependence of this interaction on the
nuclear presence of Rac1, we decided to investigate
whether Rac1 and β-catenin might physically associate in
the nucleus. To explore this possibility, we generated an
HCT116 colorectal cancer cell line with stable and doxy-
cycline-inducible expression of a constitutively active
form of Rac1 (V12Rac1). The levels of nuclear β-catenin
are inherently high in HCT116 cells due to a β-catenin
mutation that results in its stabilization, and as a conse-
quence, constitutive activation of the canonical Wnt path-
way. Nuclear extracts were isolated from cells that were
treated with or without doxycycline to induce the expres-
sion of myc-tagged V12Rac1. Immunoprecipitation with
myc-tag antibody co-precipitated β-catenin in doxycy-
cline-treated lysates but not uninduced lysates, even
though the expression level of endogenous β-catenin was
comparable under both uninduced and induced condi-
tions (Figure 1A). The reverse IP using β-catenin antibody
co-precipitated myc-tagged V12Rac1 predominantly in
induced nuclear extracts, further confirming the specificity
of the interaction. Our results suggest that active Rac1 and
β-catenin interact in the nucleus of Wnt-active HCT116
cells, albeit the interaction appears to be weak or tran-
sient.
Rac1 associates with TCF binding elements within Wnt-
responsive promoters
The functional interaction between the nuclear pool of
Rac1 and β-catenin [34], as well as the physical associa-
tion between Rac1 and β-catenin in the nucleus, led us to
explore the possibility that Rac1 associates with the β-cat-
enin/TCF transcription factor complex at Wnt-responsive
promoters. We conducted chromatin immunoprecipita-
tion (ChIP) assays to examine the in vivo association of
active Rac1 with TCF-binding elements (TBEs) located
within the promoters of two well-established Wnt tran-
scriptional targets, c-Myc and Cyclin D1. For this purpose,
we used HCT116 cells with stable inducible expression of
V12Rac1 that were treated with or without doxycycline.
Immunoprecipitation using TCF-4 or β-catenin antibod-
ies expectedly recovered chromatin that contained TBEs of
c-Myc or Cyclin D1 promoters both in the presence and
absence of doxycycline (Figure 1B). Remarkably, under
doxycycline-induced conditions, both Rac1 and myc-tag
antibodies also enriched for chromatin that contained c-
Myc or Cyclin D1 TBEs. The specificity of these interactions
was confirmed when myc-tag antibody did not co-precip-
itate TBEs in the absence of doxycycline treatment. Con-
sistent with this, in the absence of doxycycline treatment,
Rac1-specific antibody enriched for chromatin corre-
sponding to c-Myc  or  Cyclin D1 promoters to a lesser
extent than with doxycycline treatment. The chromatin
recovered by ChIP with Rac1-specific antibody under
uninduced conditions was likely co-precipitated with
endogenous Rac1. The association between Rac1 and
TBEs was specific, since neither Rac1 nor myc-tag antibod-
ies enriched for chromatin containing the promoter
region of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH), which is devoid of TBEs. Further substantia-
tion of our ChIP results were provided by electrophoretic
mobility shift assay (EMSA), which revealed an in vitro
association between active Rac1 and TBEs [see Additional
file 2]. Taken together, our results suggest that Rac1 asso-
ciates with the β-catenin/TCF-4 transcription factor com-
plex formed at TBE-containing promoters.Molecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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Active Rac1 associates with Wnt-responsive promoters in vivo Figure 1
Active Rac1 associates with Wnt-responsive promoters in vivo. (A) HCT116 cells with stable inducible expression of 
myc-tagged V12Rac1 were treated with (+) or without (-) 0.1 μg/ml doxycyline (dox) for 24 hours. Nuclear extracts were 
immunoprecipitated (IP) with myc-tag or β-catenin antibodies and immunocomplexes were analyzed by immunoblotting (IB) 
with β-catenin and myc-tag antibodies. Nuclear protein (20 μg) was loaded to confirm exogenous expression of myc-tagged 
V12Rac1 and endogenous β-catenin expression. Topoisomerase II and Paxillin were used as markers for nuclear and cytoplas-
mic fractions, respectively. (B) HCT116 cells with stable inducible expression of myc-tagged V12Rac1 were treated with (+) or 
without (-) 0.1 μg/ml doxycycline (dox) for 24 hours. Chromatin was isolated from formaldehyde-fixed cells, and subjected to 
immunoprecipitation with TCF-4, β-catenin, Rac1, or myc-tag antibodies. IgG or no antibody were used as negative controls. 
Enriched chromatin was PCR amplified using primers that flank TBEs in c-Myc or Cyclin D1 promoters. As a negative control, 
primers specific to the GAPDH promoter, which is devoid of TBEs, were used. Input represents 10% of chromatin used for 
immunoprecipitation.
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Rac1 enhances the transcription of Wnt target genes
We have previously shown that transient transfection of
V12Rac1 activated the TOPFlash reporter in HCT116
colorectal cancer cells, whereas a dominant negative Rac1
mutant (N17Rac1) inhibited the activity of TOPFlash in
these cells [34]. To corroborate our previous observations,
we conducted a TOPFlash assay using an HCT116 cell line
with doxycycline-inducible expression of V12Rac1 and
observed that V12Rac1 expression augmented Wnt signal-
ling in this cell line [see Additional file 3]. We next exam-
ined the effect of Rac1 on the regulation of the
endogenous Wnt target gene, c-Myc. As shown in Figure
2A, doxycycline-induced expression of V12Rac1 in
HCT116 cells resulted in ~70% increase in c-Myc tran-
script levels relative to uninduced cells. To further eluci-
date the physiological role of Rac1 in the transcription of
Wnt target genes, we suppressed the expression of endog-
enous Rac1 by transfecting HCT116 cells with Rac1-spe-
cific siRNA. As shown in Figure 2B (top left), ~70%
knockdown of Rac1 was achieved using Rac1-specific
siRNA, with no suppressive effect on GAPDH transcript
levels. The decrease in Rac1 expression was specific since
siRNA targeting GAPDH had no effect on the expression
of Rac1, but suppressed the expression of GAPDH by
~70% in HCT116 cells (Figure 2B,top right). We examined
the effects of Rac1 knockdown on the transcript levels of
the endogenous Wnt target gene c-Myc, and observed a
~40% reduction (Figure 2B, bottom). Taken together, our
results suggest that Rac1 contributes to the transcriptional
activation of endogenous Wnt target genes in colorectal
cancer cells. However, we should note that because the
effects of Rac1 on the transcript levels of c-Myc are modest,
other signalling pathways are likely involved in the regu-
lation of endogenous c-Myc expression [36-38].
Tiam1 potentiates Rac1-mediated stimulation of β-
catenin/TCF-dependent transcription
Our previous work has shown that Rac1 must be in its
active, GTP-bound state in order to synergize functionally
with β-catenin. We demonstrated that only GTP-bound
active Rac1, and not the inactive GDP-bound form, could
stimulate TOPFlash activity [34]. The requirement for
Rac1 activation prompted us to investigate the potential
involvement of known regulators of Rac1 activity. Tiam1
is a Rac1-specific GEF [39] that is overexpressed in many
colorectal cancers [6,5]. To investigate the possibility that
Tiam1 plays a role in Rac1-mediated stimulation of β-cat-
enin/TCF-dependent transcription, we conducted a TOP-
Flash reporter assay. HCT116 cells transiently transfected
with wild-type Rac1 alone had no effect on TOPFlash
activity compared to baseline, while Tiam1 alone caused
a modest, 1.5-fold increase in TOPFlash activity (Figure
3A). This effect was likely modest due to the inherently
high level of Rac1 activation in these cells [34]. When
Tiam1 was co-transfected with wild-type Rac1, TOPFlash
reporter activity increased by approximately 2.5-fold com-
pared to baseline, similar to the effect of V12Rac1 [see
Additional file 3]. In contrast, Tiam1 failed to activate the
TOPFlash reporter in the presence of a dominant negative
Rac1 mutant that is constitutively inactive (N17Rac1). To
further explore the role of Tiam1 in canonical Wnt signal-
ling, we analyzed the effect of Tiam1 knock-down on β-
catenin/TCF-dependent transcription. Transfection of
HCT116 cells with Tiam1 siRNA caused a reduction in
Tiam1 transcript levels by approximately 50% (Figure 3B,
left), and significantly diminished TOPFlash reporter
activity (p < 0.05) compared to control (Figure 3B, right).
This effect was likely modest due to incomplete knock-
down of Tiam1 and due to inherently high levels of Rac1
activation in HCT116 cells, as noted above. Taken
together, these results suggest that Tiam1 may act
upstream of Rac1-mediated stimulation of the canonical
Wnt pathway.
We previously showed that only the active, GTP-bound
form of Rac1 associated with β-catenin in vivo. Neither
ectopic wild-type Rac1, nor the inactive GDP-bound form
of Rac1 could physically associate with β-catenin [34].
Given our findings that Tiam1 mediates the stimulatory
effects of Rac1 on Wnt target gene transcription, we
sought to determine whether Tiam1 could influence the
interaction between Rac1 and β-catenin. HCT116 cells
were transiently transfected with either myc-tagged wild-
type Rac1 alone or myc-tagged wild-type Rac1 together
with Tiam1, and cell lysates were immunoprecipitated
with β-catenin antibody. In the absence of Tiam1 cotrans-
fection, myc-tagged wild-type Rac1 was not efficiently co-
precipitated with β-catenin antibody (Figure 3C). Intrigu-
ingly, a strong association between β-catenin and myc-
tagged wild-type Rac1 was observed only in the presence
of exogenous Tiam1. These results suggest that Tiam1 pro-
motes the association between wild-type Rac1 and β-cat-
enin in HCT116 cells.
Tiam1 associates with β-catenin in vivo
Since Tiam1 could influence the association between β-
catenin and Rac1, we were prompted to determine
whether Tiam1 itself could physically interact with β-cat-
enin in colorectal cancer cells. Protein lysates derived
from HCT116 cells were immunoprecipitated with Tiam1
antibody to "pull-down" endogenous Tiam1. Interest-
ingly, immunoblotting with β-catenin-specific antibody
revealed a robust association between endogenous Tiam1
and endogenous β-catenin (Figure 3D). As expected,
Tiam1 antibody co-precipitated Rac1 in these colorectal
cancer cells. Our results suggest that endogenous Tiam1
and endogenous β-catenin form a complex in colorectal
cancer cells.Molecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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Rac1 enhances the transcriptional activation of Wnt target genes in HCT116 cells Figure 2
Rac1 enhances the transcriptional activation of Wnt target genes in HCT116 cells. (A) HCT116 cells with stable 
inducible expression of V12Rac1 were serum starved (0.1% FBS) and treated with (+) or without (-) 0.1 μg/ml dox for 24 
hours. Total RNA was analyzed by quantitative RT-PCR for the detection of Rac1 and c-Myc mRNA. (B) HCT116 cells were 
transiently transfected with either non-silencing (N.S.) siRNA, Rac1-specific siRNA, or GAPDH siRNA for 48 hours. Total 
RNA was analyzed by quantitative RT-PCR for the detection of Rac1 and GAPDH transcript levels (top) or c-Myc transcript 
levels (bottom). For quantitative RT-PCR experiments, transcript levels of Rac1, c-Myc, and GAPDH were normalized to tran-
script levels of β-actin. Bars represent mean ± S.E., *p < 0.05, **p < 0.005.
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Wnt3a stimulation of 293T cells promotes the convergence 
of β-catenin and Tiam1/Rac1 pathways
We next wished to determine whether the interaction
between Rac1/Tiam1 and the canonical Wnt pathway is
Wnt-dependent. To stimulate the canonical Wnt signal-
ling pathway we treated a human embryonic kidney 293T
cell line, in which the Wnt signalling pathway is inactive,
with Wnt3a-conditioned medium (Wnt3a-CM). Control
conditioned medium (L-CM) is devoid of secreted Wnt3a
protein, and was used as a negative control. We first con-
firmed the ability of Wnt3a-CM to stimulate the canonical
Wnt pathway in 293T cells by testing for stabilization of
endogenous wild-type β-catenin and the induction of
TOPFlash activity [see Additional file 4]. As expected, we
observed a robust increase in both β-catenin protein
expression and TOPFlash activity upon Wnt3a-stimula-
tion of 293T cells. To determine whether Wnt signalling
affects the activation of endogenous Rac1, we used a PAK
binding domain (PBD) pull-down assay to measure the
levels of active GTP-bound Rac1. Treatment of 293T cells
with Wnt3a-CM caused an increase in the levels of active
GTP-bound Rac1 compared to control (Figure 4A), sug-
gesting that Wnt3a stimulation increases the activation of
Rac1.
Next, we wished to determine if Wnt3a stimulation could
induce the association of endogenous Tiam1 with endog-
enous β-catenin and/or TCF-4 in 293T cells. Immunopre-
Tiam1 lies upstream of Rac1-mediated activation of the canonical Wnt pathway Figure 3
Tiam1 lies upstream of Rac1-mediated activation of the canonical Wnt pathway. (A) HCT116 cells were co-trans-
fected with pTOPFlash or pFOPFlash reporter plasmids and pCMVβ-galactosidase, in addition to the indicated expression plas-
mids: wild-type (wt) Rac1 alone (0.4 μg), Tiam1 alone (0.5 μg), wt Rac1 and Tiam1 in combination (0.4 μg and 0.5 μg, 
respectively), and N17Rac1 and Tiam1 in combination (0.4 μg and 0.5 μg, respectively). Empty vector was transfected to estab-
lish basal TOPFlash activity. Luciferase activity was normalized to β-galactosidase expression, and is expressed as total relative 
light units (RLU). Results shown are representative for three independent experiments performed in triplicate. Bars represent 
mean ± S.E. and *p < 0.05. (B) HCT116 cells were transiently co-transfected with either Tiam1-specific siRNA or control, and 
with either pTOPFlash or pFOPFlash reporter plasmids for 64 hours. Total RNA was analyzed by real time RT-PCR for the 
detection of Tiam1 transcript levels, which were normalized to transcript levels of β-actin (left). Luciferase activity was meas-
ured and normalized to β-galactosidase expression, and is expressed as total relative light units (right). Bars represent mean ± 
S.D. and *p < 0.05. (C) HCT116 cells were transfected with indicated plasmids and immunoprecipitated (IP) with β-catenin 
antibody. Immunoblotting (IB) was performed using β-catenin and myc-tag antibodies to detect myc-tagged wild-type (wt) 
Rac1. Whole cell lysates (WCL) were immunoblotted with β-catenin, myc-tag, or HA-tag antibodies to confirm expression of 
β-catenin, wild-type Rac1, or Tiam1, respectively. (D) Whole cell extracts of HCT116 cells were immunoprecipitated (IP) with 
Tiam1 antibody and analyzed by Western blotting (IB) using Tiam1, β-catenin, or Rac1 antibodies. Endogenous expression of 
these proteins was confirmed by immunoblotting whole cell lysates with indicated antibodies.
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cipitation with Tiam1 antibody co-precipitated a
considerably higher level of endogenous β-catenin pro-
tein in Wnt3a-CM treated cells compared to L-CM treated
cells (Figure 4B, top). Under reverse conditions, β-catenin
antibody co-precipitated endogenous Tiam1 to a much
greater extent upon Wnt3a stimulation (Figure 4B, bot-
tom). This is not surprising, since β-catenin expression lev-
els increase in response to Wnt3a stimulation, and hence
the amount of β-catenin available for binding to Tiam1 is
increased as well. Interestingly, we observed an interac-
tion between endogenous TCF-4 and endogenous Tiam1,
and this interaction was induced by Wnt3a stimulation
(Figure 4B, bottom). These results suggest that Wnt3a stim-
ulation promotes the association of Tiam1 with β-catenin
and TCF-4. When β-catenin immunoprecipitations were
immunoblotted for endogenous Rac1, we found that con-
siderably higher levels of Rac1 were co-precipitated with
β-catenin antibody in Wnt3a-CM-treated cells relative to
L-CM-treated cells (Figure 4B, bottom). Intriguingly,
immunoprecipitation with TCF-4 antibody co-precipi-
tated similar levels of endogenous Rac1 in both L-CM-
and Wnt3a-CM-treated cells. Therefore, it seems that
while Wnt stimulation promotes the interaction between
Rac1 and β-catenin, the interaction between TCF-4 and
Rac1 is independent of Wnt stimulation.
Wnt3a stimulation of 293T cells promotes the convergence of β-catenin and Tiam1/Rac1 pathways Figure 4
Wnt3a stimulation of 293T cells promotes the convergence of β-catenin and Tiam1/Rac1 pathways. 293T cells 
were treated with L-CM (L) or Wnt3a-CM (W) for 18 hours. (A) Activated Rac1-GTP level was determined by GST pull-down 
assay using the PAK binding domain (PBD), followed by Western blotting analysis using Rac1-specific antibody. Total Rac1 
expression was determined by Western blotting analysis of whole cell lysates. (B) Cell extracts were immunoprecipitated (IP) 
with either Tiam1 antibody (top) or β-catenin and TCF-4 antibodies (bottom) and analyzed by Western blotting using indicated 
antibodies. Whole cell lysates (WCL) were analyzed by immunoblotting (IB) to confirm expression of endogenous proteins as 
shown. Blots were probed with β-actin antibody as a loading control. (C) Cytoplasmic (CE) and nuclear extracts (NE) were 
analyzed by Western blotting using Tiam1 and β-catenin antibodies. Topoisomerase II and Paxillin antibodies were used to con-
firm the purity of nuclear and cytoplasmic fractions, respectively. (D) For ChIP assay, chromatin was subjected to immunopre-
cipitation using TCF-4, β-catenin, Rac1, and Tiam1 antibodies. Enriched chromatin was analyzed by PCR using primers that 
flank the TBEs in Wnt target genes, c-Myc and Cyclin D1. GAPDH primers, which flank a region of the GAPDH promoter that 
is devoid of TBEs, were used as a negative control.
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Tiam1 is recruited to β-catenin/TCF-4 target gene 
promoters in a Wnt-dependent manner
Having found that Tiam1 associates with the β-catenin/
TCF-4 complex in the presence of a Wnt signal, and that
active Rac1 is recruited to Wnt target gene promoters, we
aimed to determine whether Tiam1 also associates with
Wnt-responsive promoters in vivo. Tiam1 is widely charac-
terized as a cytoplasmic protein, and has only recently
been found to be localized in the nucleus [40]. We first
wished to examine the localization of Tiam1 in 293T cells
in the presence and absence of Wnt stimulation. 293T
cells were treated with L-CM or Wnt3a-CM for 18 hours
and lysates were fractionated into cytoplasmic (CE) and
nuclear fractions (NE). We observed expression of endog-
enous Tiam1 in both cytoplasmic and nuclear fractions of
both L-CM- and Wnt3a-CM-treated cells (Figure 4C). As
expected, the level of endogenous β-catenin was markedly
increased upon Wnt3a-CM treatment in both cytoplasmic
and nuclear fractions.
Once the nuclear presence of Tiam1 was established, we
asked whether Tiam1 was recruited to Wnt-responsive
promoters along with Rac1. We employed ChIP analysis
to look for occupancy of TBEs located within the promot-
ers of Wnt target genes c-Myc and CyclinD1 by Rac1 and
Tiam1. For our analyses, we used chromatin derived from
293T cells treated with either L-CM or Wnt3a-CM for 18
hours. As expected, immunoprecipitation of chromatin
with TCF-4-specific antibody co-precipitated DNA corre-
sponding to c-Myc and CyclinD1 TBEs both in the presence
and absence of Wnt stimulation (Figure 4D). Also as
expected, β-catenin antibody enriched for TBEs only after
treatment with Wnt3a-CM. Most notably, endogenous
Tiam1 associated with the TBEs of both c-Myc  and
CyclinD1 only upon Wnt3a stimulation of cells. Intrigu-
ingly, endogenous Rac1 associated with c-Myc  and
CyclinD1  TBEs both in L-CM- and Wnt3a-CM-treated
cells. None of the ChIPs conducted enriched for chroma-
tin containing the GAPDH promoter, confirming the spe-
cificity of these interactions. This data suggests that Tiam1
is recruited to Wnt-responsive promoters in a Wnt-
dependent manner, whereas Rac1 is constitutively teth-
ered to TBEs within Wnt target gene promoters.
Discussion
In this study, we report for the first time that Rac1 GTPase
and the Rac1-specific activator Tiam1 are components of
the transcriptionally active β-catenin/TCF complex at
Wnt-responsive promoters, and that the presence of Rac1
and Tiam1 within this complex serves to enhance Wnt tar-
get gene transcription. Furthermore, we provide evidence
that Tiam1 mediates the stimulatory effects of Rac1 on the
Wnt-responsive transcription factor complex in a Wnt-
dependent manner. Taken together, our results offer
insights into the mechanisms underlying the cross-talk
between Tiam1/Rac1 and the canonical Wnt pathway.
Our findings suggest that Tiam1 and Rac1 play a direct
role in enhancing the transcriptional activity of β-catenin
on Wnt-responsive promoters. In HCT116 colorectal can-
cer cells, which harbour constitutive activation of canoni-
cal Wnt signalling, ectopically expressed active Rac1
associated with TBEs within the promoters of Wnt-
responsive genes c-Myc  and  Cyclin D1. Importantly,
endogenous wild-type Rac1 was also tethered to these
promoters in the Wnt-inactive 293T cell line. While Rac1
was constitutively associated with these promoters,
Wnt3a stimulation of cells induced the recruitment of
endogenous Tiam1, along with β-catenin. Consistent with
our ChIP data, Wnt3a stimulation induced the formation
of a complex containing Tiam1 and TCF-4, whereas Rac1
associated with TCF-4 in a Wnt-independent manner. The
interaction between β-catenin and Tiam1 was also
enhanced upon Wnt3a stimulation of 293T cells. In these
cells, the nuclear localization of Tiam1 was observed both
in the presence and absence of Wnt3a stimulation, thus it
is possible that stimulation of the Wnt pathway forces β-
catenin into the nucleus where it forms a complex with
nuclear Tiam1. We found that Tiam1 was also localized in
the nucleus of HCT116 cells (data not shown). Since high
levels of nuclear β-catenin persist in HCT116 cells due to
constitutive Wnt pathway activation, it is possible that β-
catenin and Tiam1 may associate with each other in a con-
stitutive fashion in the nuclear compartments of these
cells. Furthermore, wild-type Rac1 interacted with β-cat-
enin only in the presence of Tiam1, and wild-type Rac1
required the presence of Tiam1 to enhance β-catenin/TCF-
dependent transcription. These results suggest that Tiam1
mediates the stimulatory effects of Rac1 on canonical Wnt
signalling, and this is supported by the reduction in β-cat-
enin/TCF-dependent transcription in response to Tiam1
knock-down. Since the constitutively active form of Rac1
was capable of interacting with β-catenin [34] and
enhanced transcription from Wnt-responsive promoters
in the absence of Tiam1 cotransfection, it is possible that
the recruitment of Tiam1 to the promoter under physio-
logic conditions serves to locally activate Rac1 through its
GEF activity. In line with this possibility, Wnt3a stimula-
tion of 293T cells promoted the activation of endogenous
Rac1.
We propose a model whereby in the absence of a Wnt sig-
nal, Rac1 is tethered to Wnt-responsive promoters in an
inactive, GDP-bound state along with TCF/LEF and possi-
bly co-repressor proteins (Figure 5). Upon Wnt pathway
stimulation,  β-catenin forms a complex with Tiam1,
which is recruited to Wnt target gene promoters by a pro-
moter-associated complex containing TCF/LEF and inac-
tive, GDP-bound Rac1. We propose that Tiam1 activatesMolecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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Rac1 by catalyzing GDP to GTP exchange, and thereby
mediates the stimulatory effects of Rac1 on the Wnt-
induced transcription factor complex, resulting in the
enhanced transcription of a subset of Wnt target genes,
including genes that promote unrestricted cell prolifera-
tion such as c-Myc and Cyclin D1. The contribution of
Tiam1-mediated activation of Rac1 to the upregulation of
such tumour-promoting genes may represent one mecha-
nism by which the Tiam1/Rac1 signalling module con-
tributes to tumour development in the colon. The status
of Cyclin D1 as a direct target of the Wnt pathway has
recently been disputed by Sansom et al., who demon-
strated that Cyclin D1 was not immediately upregulated
following loss of APC in the murine small intestine [41].
More recently, however, β-catenin and other coactivators
of Wnt target gene transcription were shown to be
recruited to the Cyclin D1 promoter in a myoblast cell line
in response to Wnt pathway stimulation [42]. This study
and several others that provide evidence for the require-
ment of TBEs for Cyclin D1 expression [15,16] suggest that
the status of Cyclin D1 as a direct Wnt target may be
dependent on cell type.
Additional supporting evidence for our model was
recently provided by studies comparing tumour forma-
tion in Min/+ mice (with a heterozygous nonsense muta-
tion in the APC gene that leads to constitutive activation
of the canonical Wnt pathway) with different Tiam1 back-
grounds [5]. Min/+ mice in a Tiam1 -/- background had a
significantly reduced susceptibility to develop Wnt-
induced intestinal and mammary tumours in comparison
to Tiam1 +/+/Min/+ mice, and the growth of tumours that
did develop was significantly impaired. These studies are
consistent with a role for Tiam1/Rac1 in the amplification
of nuclear Wnt signalling in colon cancer cells.
Collectively, the results of our study implicate Rac1 and
the Rac1-specific GEF Tiam1 as coactivators of β-catenin/
TCF-dependent transcription. Consistent with the idea
that Rho proteins and their GEFs may act as transcrip-
tional coactivators, a recent study reported a similar role
for RhoA, another member of the Rho GTPase family, and
the RhoA-specific GEF, Brx. RhoA and Brx were both
found to interact with glucocorticoid receptor (GR) at GR-
responsive promoters and this interaction increased the
transcriptional activity of GR [43]. Furthermore, a recent
study demonstrated a direct interaction between Rac1 and
activated STAT transcription factors in the nucleus [44],
while Tiam1 was shown to interact directly with the tran-
scription factor c-Myc in the nucleus to negatively regulate
its transcriptional activity [40]. The finding that tradition-
ally cytoplasmic Rho proteins and their regulators are
emerging as important nuclear signal transducers raises
the possibility that such proteins may be directly involved
in the coordination of cytoplasmic events and changes in
Proposed model of Rac1/Tiam1-mediated enhancement of β-catenin/TCF-4-dependent transcription Figure 5
Proposed model of Rac1/Tiam1-mediated enhancement of β-catenin/TCF-4-dependent transcription. In the 
absence of a Wnt signal, Rac1 is tethered to TCF binding elements (TBEs) within Wnt target gene promoters along with TCF-
4 and possibly other corepressors in the GDP-bound inactive state. Wnt3a stimulation promotes the formation of β-catenin/
Tiam1 complexes that associate with TCF-4 and Rac1 at Wnt target gene promoters. Tiam1 activates Rac1 by mediating GDP 
to GTP exchange. GTP-bound active Rac1 mediates stimulatory effects on the Wnt-induced transcription factor complex to 
enhance Wnt target gene transcription.
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gene expression that occur in response to specific
upstream signals.
Rac1 enters the nucleus via a recently identified nuclear
localization signal (NLS) within its C-terminal polybasic
region (PBR) [10]. A previous study has shown that Rac1
promotes the nuclear accumulation of SmgGDS, a GEF for
Rho GTPases, through its PBR [45]. It is possible that the
PBR of Rac1 similarly facilitates the nuclear accumulation
of Tiam1. We speculate that recruitment of Tiam1 to Wnt-
responsive promoters may serve to locally catalyze GDP to
GTP exchange on promoter-associated Rac1, juxtaposing
active, GTP-bound Rac1 and components of the β-cat-
enin/TCF-dependent transcription factor complex.
Because GTP-bound Rac1 acts as a molecular switch, it is
possible that its presence at the promoter may serve to
influence the activation of such components. Previously,
active Rac1 and the histone acetyl transferase CBP/p300
were shown to synergize to enhance NF-AT-mediated
transcriptional activation in T-cells [46]. It is tempting to
speculate that Rac1 might augment β-catenin/TCF-
dependent transcription of target genes by influencing the
activity of CBP/p300. Alternatively, Rac1 may exert its
stimulatory effects on β-catenin/TCF-mediated transcrip-
tion in colon cancer cells though the downstream effector
protein Pak1. A recent study demonstrated that Pak1
modulates the transcription of target genes through direct
association with chromatin, and possibly though its abil-
ity to modify Histone H3 [12,47]. Intriguingly, a recent
study has shown that Pak1 expression is upregulated in
adenomas and invasive colon cancers relative to normal
colonic epithelium [48]. Whether Pak1 contributes to
Tiam1/Rac1-mediated activation of the Wnt pathway war-
rants further investigation.
Tiam1 was recently identified as a Wnt-responsive gene
that is upregulated in mouse intestinal tumors and
human colon adenomas, and promotes intestinal tumour
formation and progression [6,35]. Whether Tiam1  is a
downstream target of the cross-talk between Wnt and
Tiam1/Rac1 signalling pathways is currently being inves-
tigated in our lab. Such a finding would suggest the possi-
ble existence of a positive feedback loop, whereby
aberrant activation of the Wnt pathway induces the tran-
scription of a subset of Wnt target genes such as Tiam1,
which may mediate the activation of Rac1. As our results
suggest, Tiam1-mediated Rac1 activation may feed back to
augment nuclear Wnt signalling, leading to sustained
Tiam1/Rac1 signalling and as a consequence, the
enhanced transcription of target genes that may be impor-
tant for tumour initiation and/or progression. Future
studies will be aimed at exploring the possible existence of
such a positive feedback loop.
Conclusion
The present study sheds some light on the mechanism
underlying the cross-talk between the Tiam1/Rac1 signal-
ling pathway and the canonical Wnt pathway in colorectal
cancer cells. Our results also suggest a novel nuclear role
for Rac1 and its activator Tiam1. We have demonstrated
for the first time that Tiam1/Rac1 associate with the β-cat-
enin/TCF transcription factor complex at Wnt-responsive
promoters to enhance Wnt target gene transcription.
Future studies aimed at elucidating the mechanisms that
underlie the ability of Tiam1/Rac1 to directly regulate β-
catenin/TCF-dependent gene transcription, as well as the
identification of novel chromatin targets of Tiam1/Rac1,
will provide important insights into the novel roles of
these proteins in the nucleus.
Methods
Cell culture
HCT116 cells (ATCC) were cultured in McCoy's 5A media
supplemented with 10% fetal bovine serum (FBS).
HCT116 cells with stable inducible expression of V12Rac1
or N17Rac1 were cultured in McCoy's 5A media supple-
mented with 10% FBS, 5 μg/ml blasticidin and 300 μg/ml
zeocin. 293T cells were cultured in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% FBS. L-
cells and Wnt3a-expressing L-cells (gifts from Dr. Liliana
Attissano, University of Toronto) were maintained in
DMEM supplemented with 10% FBS. Wnt3a-expressing L-
cells were additionally supplemented with 400 μg/ml
G418. For the preparation of L- and Wnt3a-CM, CM was
collected from cultured parental L-cells or Wnt3a-express-
ing L-cells and was diluted to 50% in serum-free DMEM.
All cell lines were cultured at 37°C in a humidified atmos-
phere of 5% CO2.
Antibodies
Antibodies used for co-immunoprecipitation analyses
were as follows:β  -catenin (H-102), myc-tag (A-14),
Tiam1 (C-16), TCF-4 (H-125) (all from Santa Cruz Bio-
technology, Santa Cruz, CA). Antibodies used for immu-
noblotting were as follows: β-catenin (Transduction
Laboratories, BD Biosciences), myc-tag (9E10, Santa Cruz
Biotechnology), Rac1 (Transduction Laboratories, BD
Biosciences), Topoisomerase II (Oncogene Research Prod-
ucts, Boston, MA), Paxillin (Transduction Laboratories,
BD Biosciences), β-actin (Sigma-Aldrich, St. Louis, MO)
and HA-tag (HA-7, Sigma-Aldrich). Antibodies used for
chromatin immunoprecipitation assays were as follows:
TCF-4 (H-125, Santa Cruz Biotechnology) or TCF-4 (6H5-
3, Upstate Biotechnology, Lake Placid, NY), β-catenin (H-
102, Santa Cruz Biotechnology), Rac1 (C-14, Santa Cruz
Biotechnology), myc-tag (A-14, Santa Cruz Biotechnol-
ogy), and Tiam1 (C-16, Santa Cruz Biotechnology).Molecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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Plasmids
2 × myc-tagged V12Rac1/pcDNA3.1 was purchased from
UMR cDNA Resource Center (Rolla, MO). pcDNA6/TR
encoding Tet repressor and pcDNA4/TO inducible expres-
sion vector were included in the T-REx system, which was
purchased from Invitrogen Life Technologies. To generate
the doxycycline inducible 2 × myc-tagged V12Rac1/
pcDNA4/TO construct, 2 × myc- V12Rac1/pcDNA3.1 was
digested with Hind III and Xba I and the fragment encod-
ing 2 × myc-V12Rac1 was subcloned into Hind III and
Xba I-digested pcDNA4/TO. pTOPFlash and pFOPFlash
luciferase constructs, and dominant-negative TCF-4 con-
struct were gifts from Dr. Benjamin Alman (Hospital for
Sick Children, Toronto). The plasmid encoding myc-
tagged wild-type Rac1 was a gift from Dr. Tony Pawson
(SLRI, Mount Sinai Hospital, Toronto). Wild-type Tiam1
construct was a gift from Dr. John Collard (Netherlands
Cancer Institute, Netherlands).
Generation of stable inducible cell lines
T-REx system (Invitrogen Life Technologies) was
employed to generate HCT116 cell lines with stable
inducible expression of V12Rac1 according to manufac-
turer's instructions. HCT116 cells were transfected in 10-
cm dishes with 13 μg pcDNA6/TR per plate using Lipo-
fectAMINE 2000 (Invitrogen) transfection reagent. Forty-
eight hours after transfection, cells were re-seeded into 15-
cm plates at low density and transfectants were selected
for in the presence of 5 μg/ml blasticidin. Resistant colo-
nies were screened by Western blotting. Positive clones
were subsequently transfected with 2 × myc-V12Rac1/
pcDNA4/TO in 10-cm dishes as described above and
selected for with 300 μg/ml zeocin. To screen resistant col-
onies, cells were treated with either 1 μg/ml doxycycline
(dox) or vehicle (water), and protein lysates were har-
vested after 24 hours and analyzed by Western blotting.
Positive clones were maintained in blasticidin and zeocin.
Coimmunoprecipitations, cell fractionation, and Western 
blotting
For analysis of nuclear lysates by coimmunoprecipitation,
nuclear extracts were isolated using Nuclear Complex Co-
IP Kit (Active Motif, Carlsbad, CA, USA) and immunopre-
cipitations were carried out according to manufacturer's
instructions. Nuclear extracts (500 μg) were subjected to
immunoprecipitation using 3 μg antibody. Coimmuno-
precipitation analysis of HCT116 whole cell lysates was
performed as described [34]. Whole cell lysates (1000 μg)
were subjected to immunoprecipitation using 3 μg anti-
body. For analysis of 293T cells by coimmunoprecipita-
tion, whole cell lysates (500 μg) were
immunoprecipitated with 3 μg antibody. Immunocom-
plexes were resolved on 10% SDS-PAGE gel, and analyzed
by Western blotting using indicated antibodies. For cell
fractionation analysis, the NE-PER kit (Pierce, Rockford,
IL) was used according to manufacturer's instructions.
Chromatin immunoprecipitation (ChIP) assay
ChIP assay was performed using a ChIP-IT kit (Active
Motif, Carlsbad, CA, USA) according to manufacturer's
instructions. Sonication conditions were 15 × 20s to 20 ×
20s, and generated 200–1000 bp fragments. Chromatin
was immunoprecipitated using 4 μg indicated antibodies.
Recovered DNA was analyzed by PCR using primer pairs
that flank TBEs in c-Myc or Cyclin D1 promoters. GAPDH
primers, which flank a region of the GAPDH promoter
that is devoid of TBEs, were used as a negative control. The
c-Myc  primers were: forward, 5'-GCTCTCCACTT-
GCCCCTTTTA-3', and reverse, 5'-GTTCCCAATTTCT-
CAGCC-3'. The Cyclin D1 primers were: forward, 5'-
GACTACAGGGGAGTTTTGTTG-3', and reverse, 5'-TCG-
GCTCTCGCTTCTGCTG-3'. The GAPDH  primers were:
forward, 5'-TACTAGCGGTTTTACGGGCG-3', and reverse,
5'-TCGAACAGGAGGAGCAGAGA-GCGA-3'. PCR prod-
ucts were run on a 2% agarose gel and visualized with
ethidium bromide. Additional data describing Electro-
phoretic Mobility Shift Assay (EMSA) are described in
[Additional file 1].
Reporter gene assay
Cells were transiently transfected using LipofectAMINE
2000 reagent (Invitrogen Life Technologies) according to
manufacturer's instructions. Cells were seeded in 24-well
plates at a density of 2 × 105 cells per well. Twenty-four
hours post-seeding, cells were transfected with 0.1 μg luci-
ferase reporter gene plasmid containing either four wild-
type (pTOPFlash) or mutant (pFOPFlash) TCF binding
elements repeated in tandem upstream of a luciferase
reporter gene. Cells were co-transfected with various
amounts of plasmid DNA, as indicated in figure legends.
The total amount of DNA per transfection was held con-
stant at 1.03 μg total plasmid DNA by co-transfection with
appropriate amounts of empty vector (pcDNA3.1). Cells
were co-transfected with 0.03 μg of plasmid encoding β-
galactosidase (pCMVβ-gal) as an internal control. Luci-
ferase and β-galactosidase activities were measured 24
hours after transfection. Luciferase values were normal-
ized to β-galactosidase expression. For statistical analyses,
unpaired Student's t-test was performed. Additional
reporter gene assay methods are described in [Additional
file 1].
Quantitative Reverse Transcriptase (RT)-PCR
Total RNA was isolated using an RNeasy Mini kit (Qiagen,
Valencia, CA) and analyzed by real-time RT-PCR as
described [49]. For RNAi experiments, cells were trans-
fected with either: SMARTpool Rac1-specific siRNA, ON-
TARGETplus SMARTpool Tiam1-specific siRNA, siCON-
TROL non-silencing siRNA as a control, GAPDH-specificMolecular Cancer 2008, 7:73 http://www.molecular-cancer.com/content/7/1/73
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siRNA as a control (Dharmacon, Lafayette, CO.) or mock
transfected using LipofectAMINE 2000 according to man-
ufacturer's protocol. After 48 hours (Rac1 siRNA experi-
ments) or 64 hours (Tiam1 siRNA experiments), total
RNA was isolated and analyzed by real-time RT-PCR. The
following primer pairs were used to amplify cDNA: c-Myc
forward, 5'-GCCAAGCTCGTCTCAGAGAAG-3', and
reverse, 5'-CAGAAGGTGATCCAGACTCTG-3'; Rac1 for-
ward, 5'-ATGCAGGCCATCAAGTGTGTG-3', and reverse,
5'-TTACAACAGCAGGCATTTTCTCT-3'; Tiam1 forward,
5'-AGACGTACTCAGGCCATGTC-3', and reverse,
5'ACCCAAATGTCGCAGTCAGG-3';  β-actin forward, 5'-
ATCATGTTTGAGACCTTCAA-3', and reverse, 5'-
CATCTCTTGCTCGAAGTCCA-3', and; GAPDH forward,
5'-ACCACAGTCCATGCCATCAC-3', and reverse, 5'-
TCCACCACCCTGTTGCTGTA-3'. For statistical analyses,
unpaired Student's t-test was performed.
Rac1 activation assay
Endogenous active GTP-bound Rac1 levels were deter-
mined using a PAK binding domain (PBD) pull-down
assay (EZ-Detect Rac1 activation kit, Pierce Biotechnol-
ogy, Rockford, IL) according to the manufacturer's proto-
col. Briefly, cells were washed in cold PBS and lysed on ice
in 500 μl lysis buffer. Total lysates were cleared by centrif-
ugation at 16000 × g for 15 mins. 100 μL of the lysate was
kept for protein quantitation of total Rac1 protein. The
remaining lysate was incubated for 1 hour at 4°C with 20
μg PBD agarose beads. Precipitated complexes were
washed three times with excess lysis buffer. After the final
wash, the supernatant was discarded and the beads were
suspended in 40 μl of 2 × Laemmli sample buffer. Levels
of total Rac1 and active Rac1 were then analyzed by West-
ern blotting.
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